ITGA2B and Thrombocytopenia: In the analysis restricted to intravenous GP IIb–IIIa inhibitors, the occurrence of thrombocytopenia was higher with abciximab (RR = 2.93) and tirofiban (RR = 2.79) but not eptifibatide (RR = 1.05).